Abstract:Objective To investigate the efficacy and postoperative recovery of fully biodegradable sinus drug stents in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).Methods A total of 120 CRSwNP patients who underwent endoscopic sinus surgery at our hospital between August 2022 and October 2024 were selected and randomly divided into two groups, the observation group and the control group, with 60 patients in each group. Both groups underwent endoscopic sinus surgery. The observation group received the implantation of fully biodegradable sinus drug stents before the end of the surgery, while the control group received postoperative nasal irrigation and spray treatment with budesonide. Postoperative recovery was assessed by comparing symptom improvement time, postoperative complications, recurrence rate, and clinical effectiveness. Nasal structure, nasal airway resistance, Lund-Mackay sinus CT scores, and nasal endoscopy scores were compared between the two groups before and after treatment.Results The observation group showed shorter recovery time for nasal ventilation, mucosal recovery, and hospital stay compared to the control group (P < 0.05). The differences in Lund-Mackay scores, polyp scores, edema scores, and nasal secretion scores before and after treatment, as well as scarring/crusting scores post-treatment, were all lower in the observation group than in the control group (P < 0.05). The observation group had a lower incidence of postoperative complications and recurrence rates compared to the control group (P < 0.05), and a higher total effective rate (P < 0.05).Conclusion Fully biodegradable sinus drug stents have significant clinical effects in patients with chronic rhinosinusitis with nasal polyps. They accelerate postoperative recovery, reduce complications and recurrence rates, and have high clinical application value.